Rosen Alexander Gustaf Erik 4

What Happened

• Rosen Alexander Gustaf Erik, Chief Administrative Officer of Jupiter Neurosciences (JUNS), converted/exercised derivative awards into common stock on June 2, 2025. The filing reports two conversion events: 164,553 shares and 96,608 shares acquired (total 261,161), with corresponding reported dispositions of 164,554 and 96,608 shares (total 261,162). The conversion entries show $0.00 proceeds, indicating no cash was exchanged as part of the conversion/exercise.

Key Details

• Transaction date: 2025-06-02 (reported on Form 4 filed 2026-07-13 — the filing is late)
• Transaction codes: M = exercise or conversion of a derivative/security
• Share counts: 164,553 and 96,608 shares converted (acquired); matching disposals of 164,554 and 96,608 shares
• Dollar values: $0.00 reported on the disposition lines — no cash proceeds from these conversions
• Footnotes: F1 — the securities convert into common stock on a one-for-one basis; F2 — the awards vested upon expiration of the issuer’s IPO lock-up period
• Shares owned after the transaction: not specified in the filing

Context

• This was a conversion/exercise of derivative awards that vested after the IPO lock-up expired, not an open‑market sale or purchase. The $0.00 disposition amounts reflect conversion/settlement mechanics rather than a market sale; they do not indicate proceeds to the insider. The Form 4 was filed more than a year after the transaction date, which is late and may reduce the timeliness value for investors tracking insider activity.